Health Catalyst, Inc.
HCAT
$1.34
-$0.14-9.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.90% | -6.19% | -0.04% | 6.35% | 6.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.90% | -6.19% | -0.04% | 6.35% | 6.28% |
| Cost of Revenue | -15.87% | -21.13% | -11.23% | 6.04% | 9.14% |
| Gross Profit | -5.44% | 12.98% | 13.72% | 6.69% | 3.29% |
| SG&A Expenses | -19.47% | -13.17% | 2.78% | 6.87% | -13.78% |
| Depreciation & Amortization | -1.66% | 25.48% | 26.35% | 19.02% | 17.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.66% | -16.05% | -5.17% | 4.98% | 0.31% |
| Operating Income | 50.32% | 75.67% | 37.27% | 3.62% | 24.48% |
| Income Before Tax | -370.15% | -352.14% | -45.96% | -204.16% | -14.91% |
| Income Tax Expenses | 92.56% | -39.36% | 108.63% | 15.71% | 90.27% |
| Earnings from Continuing Operations | -367.64% | -340.31% | -50.95% | -203.18% | -15.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -367.64% | -340.31% | -50.95% | -203.18% | -15.33% |
| EBIT | 50.32% | 75.67% | 37.27% | 3.62% | 24.48% |
| EBITDA | 144.85% | 216.26% | 137.33% | 47.14% | 57.78% |
| EPS Basic | -341.64% | -286.87% | -29.68% | -158.23% | 1.45% |
| Normalized Basic EPS | 39.31% | 56.57% | 22.78% | -35.28% | 7.49% |
| EPS Diluted | -341.64% | -286.87% | -29.68% | -158.23% | 1.45% |
| Normalized Diluted EPS | 39.31% | 56.57% | 22.78% | -35.28% | 7.49% |
| Average Basic Shares Outstanding | 5.89% | 13.82% | 16.44% | 17.40% | 17.00% |
| Average Diluted Shares Outstanding | 5.89% | 13.82% | 16.44% | 17.40% | 17.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |